Your browser doesn't support javascript.
loading
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
Tandstad, T; Ståhl, O; Dahl, O; Haugnes, H S; Håkansson, U; Karlsdottir, Å; Kjellman, A; Langberg, C W; Laurell, A; Oldenburg, J; Solberg, A; Söderström, K; Stierner, U; Cavallin-Ståhl, E; Wahlqvist, R; Wall, N; Cohn-Cedermark, G.
Afiliação
  • Tandstad T; The Cancer Clinic, St Olavs University Hospital, Trondheim, Norway torgrim.tandstad@stolav.no.
  • Ståhl O; Department of Oncology, Skane University Hospital, Lund, Sweden.
  • Dahl O; Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen Department of Oncology, Haukeland University Hospital, Bergen.
  • Haugnes HS; Institute of Clinical Medicine, University of Tromsø, Tromsø Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
  • Håkansson U; Department of Urology, Skåne University Hospital, Malmö
  • Karlsdottir Å; Department of Oncology, Haukeland University Hospital, Bergen.
  • Kjellman A; Division of Urology, Karolinska University Hospital, Stockholm, Sweden.
  • Langberg CW; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Laurell A; Uppsala University Hospital, Uppsala, Sweden.
  • Oldenburg J; Department of Oncology, Akershus University Hospital, Lørenskog Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Solberg A; The Cancer Clinic, St Olavs University Hospital, Trondheim, Norway.
  • Söderström K; Norrland University Hospital, Umeå
  • Stierner U; Department of Oncology, Sahlgrenska University Hospital, Gothenburg Sahlgrenska Academy University of Gothenburg, Gothenburg, Sweden.
  • Cavallin-Ståhl E; Department of Oncology, Skane University Hospital, Lund, Sweden.
  • Wahlqvist R; Department of Urology, Oslo University Hospital, Oslo, Norway.
  • Wall N; Institute of Clinical and Experimental Medicine, University of Linköping, Linköping Department of Oncology, Linköping University Hospital, Linköping.
  • Cohn-Cedermark G; Department of Oncology-Pathology, Karolinska Institute, Stockholm Karolinska University Hospital, Stockholm, Sweden.
Ann Oncol ; 27(7): 1299-304, 2016 07.
Article em En | MEDLINE | ID: mdl-27052649
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carboplatina / Quimioterapia Adjuvante / Seminoma / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carboplatina / Quimioterapia Adjuvante / Seminoma / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Ano de publicação: 2016 Tipo de documento: Article